146 / 464
146
SCIENTIFIC PROGRAMME
| Programme and Exhibition Guide
MONDAY 8 MAY 2017
15:45 > Variation in bladder volume and associated spatial dose metrics in
prostate and pelvic radiotherapy
O. Casares-Magaz (Denmark), V. Moiseenko, A. Hopper, N.J. Pettersson,
M. Thor, R. Knopp, J.O. Deasy, L.P. Muren, J. Einck
OC-0489
15:55 > A robust and fast planning approach for adaptive MR-guided treatment
of pancreatic cancer
M.A. Palacios (The Netherlands), O. Bohoudi, A. Bruynzeel, B. Slotman,
S. Senan, F. Lagerwaard
OC-0490
16:05 > Quality assurance of a novel table mounted imaging device integrated
in a patient positioning system
A. Utz (Austria), A. Ableitinger, A. Zechner, M. Mumot, M. Teichmeister,
P. Steininger, H. Deutschmann, M. Stock
OC-0491
SYMPOSIUM
Focus on prostate cancer: what is the best of radiotherapy we need to
treat our patients with
14:45 - 16:15 | STRAUS 1
This symposia will be cover the biology of prostate cancer and its pertinence for the
alpha/beta ratio, the impact of the alpha/beta ratio for hypofractionation rationale
and to assess the potential of dose escalation that incorporates hypofractionation
and biology and what is needed to achieve it. It will be further on evaluate the
possible benefits and pitfalls of rectal spacers to minimise the dose to the rectum in
radiotherapy for prostate cancer.
The other part will give an overview of the MRI-guided radiation therapy system. It
will be discuss the clinical implementation and workflow of stereotactic MR-guided
adaptive radiation therapy (SMART) for prostate cancer. Also will discuss details on
daily plan adaptation and gated radiation delivery under real-time MRI-guidance.
Chair: A. Osztavics (Austria)
Co-chair: R. Harasleben (Austria)
14:45 > What are the best ingredients to deliver the optimal radiotherapy for
prostate cancer
Speaker: V. Khoo (UK)
SP-0492
15:15 > The role of spacers in the era of highly conformal, hypo-fractionated,
image guided, adaptive radiotherapy of the prostate
Speaker: P. Scherer (Austria)
SP-0493
15:45 > Using a MRI-guided radiation therapy system for prostate cancer
patients
Speaker: O. Bohoudi (The Netherlands)
SP-0494